Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 26
Filtrer
1.
Pesqui. vet. bras ; 40(6): 474-478, jun. 2020. tab
Article de Anglais | VETINDEX | ID: vti-31965

RÉSUMÉ

This work aimed to evaluate the effect of platelet-rich plasma (PRP) on advancement skin flaps in dogs regarding improvement of vascularization, with focus on increasing its viable area, since there are reports that it is a potential angiogenesis stimulator. The experimental group was composed of eight adult bitches, in which two advancement skin flaps were made in the ventral abdominal region. No product was applied in the control flap (CF), while PRP was used in the contralateral flap, called treated flap (TF). The areas were clinically evaluated every two days until the 7th postoperative day regarding skin color and presence of necrosis. At 10 days, both flaps were removed and submitted to histological examination and blood vessel morphometry. The vessels counted in each group were statistically analyzed by the F-test at 1% probability. Results showed no significant difference in macroscopic changes in the wound, or CF and TF vascularization, thus suggesting that PRP gel did not improve advancement skin flap angiogenesis in bitches under the experimental conditions in which this research was developed.(AU)


Objetivou-se com o presente artigo avaliar a ação angiogênica do gel de plasma rico em plaquetas (PRP) em flapes cutâneos de avanço em animais da espécie canina, visando aumentar a viabilidade da pele após o procedimento, uma vez que existem relatos de que o produto é um potente estimulador da angiogênese. O grupo experimental foi composto por oito cadelas adultas, onde foram confeccionados dois flapes de avanço (de padrão subdérmico) na região abdominal ventral. Em um dos flapes, considerado controle (FC) não foi aplicado nenhum produto, enquanto que no flape contralateral, denominado tratado (FT), foi usado o gel de PRP. As áreas foram macroscopicamente avaliadas a cada dois dias até o 7º dia de pós-operatório em relação à coloração da pele e presença de área de necrose, e com 10 dias ambos os flapes foram coletados por biópsia e submetidos ao exame histológico e morfometria dos vasos sanguíneos. Os vasos contados em cada grupo foram estatisticamente analisados pelo teste de F ao nível de 1% de probabilidades. Os resultados demonstraram que não houve diferença significativa nas alterações macroscópicas das feridas e na morfometria vascular dos FC e FT, sugerindo dessa maneira que dentro das condições experimentais nas quais a pesquisa foi executada, que o gel de PRP não incrementou a angiogênese de flapes de avanço em cadelas.(AU)


Sujet(s)
Animaux , Chiens , Transplantation de peau/médecine vétérinaire , Agents angiogéniques/usage thérapeutique , Plasma riche en plaquettes
2.
Pesqui. vet. bras ; Pesqui. vet. bras;40(6): 474-478, June 2020. tab
Article de Anglais | VETINDEX, LILACS | ID: biblio-1135644

RÉSUMÉ

This work aimed to evaluate the effect of platelet-rich plasma (PRP) on advancement skin flaps in dogs regarding improvement of vascularization, with focus on increasing its viable area, since there are reports that it is a potential angiogenesis stimulator. The experimental group was composed of eight adult bitches, in which two advancement skin flaps were made in the ventral abdominal region. No product was applied in the control flap (CF), while PRP was used in the contralateral flap, called treated flap (TF). The areas were clinically evaluated every two days until the 7th postoperative day regarding skin color and presence of necrosis. At 10 days, both flaps were removed and submitted to histological examination and blood vessel morphometry. The vessels counted in each group were statistically analyzed by the F-test at 1% probability. Results showed no significant difference in macroscopic changes in the wound, or CF and TF vascularization, thus suggesting that PRP gel did not improve advancement skin flap angiogenesis in bitches under the experimental conditions in which this research was developed.(AU)


Objetivou-se com o presente artigo avaliar a ação angiogênica do gel de plasma rico em plaquetas (PRP) em flapes cutâneos de avanço em animais da espécie canina, visando aumentar a viabilidade da pele após o procedimento, uma vez que existem relatos de que o produto é um potente estimulador da angiogênese. O grupo experimental foi composto por oito cadelas adultas, onde foram confeccionados dois flapes de avanço (de padrão subdérmico) na região abdominal ventral. Em um dos flapes, considerado controle (FC) não foi aplicado nenhum produto, enquanto que no flape contralateral, denominado tratado (FT), foi usado o gel de PRP. As áreas foram macroscopicamente avaliadas a cada dois dias até o 7º dia de pós-operatório em relação à coloração da pele e presença de área de necrose, e com 10 dias ambos os flapes foram coletados por biópsia e submetidos ao exame histológico e morfometria dos vasos sanguíneos. Os vasos contados em cada grupo foram estatisticamente analisados pelo teste de F ao nível de 1% de probabilidades. Os resultados demonstraram que não houve diferença significativa nas alterações macroscópicas das feridas e na morfometria vascular dos FC e FT, sugerindo dessa maneira que dentro das condições experimentais nas quais a pesquisa foi executada, que o gel de PRP não incrementou a angiogênese de flapes de avanço em cadelas.(AU)


Sujet(s)
Animaux , Chiens , Transplantation de peau/médecine vétérinaire , Agents angiogéniques/usage thérapeutique , Plasma riche en plaquettes
3.
Rev. cuba. oftalmol ; 33(1): e830, ene.-mar. 2020.
Article de Espagnol | LILACS, CUMED | ID: biblio-1126728

RÉSUMÉ

RESUMEN El pterigión se trata de un crecimiento fibrovascular de morfología triangular que se extiende desde la conjuntiva hacia la córnea. Está clasificado dentro de las degeneraciones no involutivas o tumoraciones epiteliales benignas corneales y se presenta en el 10,2 por ciento de la población. El tratamiento quirúrgico es el más indicado, y tiene una tasa de recidiva independientemente de la técnica quirúrgica utilizada del 10,7 por ciento; esta tasa de recidiva se evidencia por la neovascularización y el tejido cicatrizal antes de los dos meses después de la cirugía. Lo anterior ha incentivado la investigación de nuevos tratamientos que disminuyan esta complicación, por lo que el objetivo de esta revisión bibliográfica fue la búsqueda de alternativas terapéuticas para el pterigión recidivante. Se realizó una búsqueda automatizada sobre el tema, utilizando la plataforma Infomed, cuya información fue resumida para la elaboración del informe final. Concluimos que existen diferentes tratamientos adyuvantes para disminuir la tasa de recurrencia, y es necesario realizar estudios donde se determine el tiempo y la frecuencia en la aplicación de estos para obtener resultados más efectivos en su uso(AU)


ABSTRACT Pterygium is a fibrovascular growth of triangular shape that extends from the conjunctiva to the cornea. It has been classified as a noninvolutionary degeneration or benign corneal epithelial tumor which affects 10.2 percent of the population. The treatment most commonly indicated is surgery, which has a recurrence rate of 10.7 percent, irrespective of the surgical technique used. Recurrence takes the form of neovascularization and scar tissue within two months after surgery. This has fostered research into new treatments to reduce this complication. The objective of the present bibliographic review was precisely to search for therapeutic alternatives for recurrent pterygium. An automated search was conducted about the topic on the platform Infomed. Data were summarized to write the final report. We concluded that there are several adjuvant treatments to reduce recurrence, and it is necessary to carry out studies determining the time and frequency of their application to obtain more effective results(AU)


Sujet(s)
Humains , Ptérygion/chirurgie , Ptérygion/épidémiologie , Agents angiogéniques/usage thérapeutique , Transplantation de cornée/méthodes
4.
Acta cir. bras. ; 34(12): e201901202, 2019. ilus
Article de Anglais | VETINDEX | ID: vti-15345

RÉSUMÉ

Purpose To explore the potential role and unclear molecular mechanisms of vaccarin in wound healing. Methods Rats skin excision model to study the effects of vaccarin on wound healing in vivo . Hematoxylin and eosin staining was performed to evaluate Histopathologic characteristics. Immunohistochemistry was employed to assess the effects of vaccarin in accelerating angiogenesis. Western blot was used to evaluate relative protein expressed levels. Results Vaccarin could significantly promote wound healing and endothelial cells and fibroblasts proliferation in the wound site. Immunohistochemistry and Western blot studies showed that the nodal proteins and receptor (bFGFR) related to angiogenesis signaling pathway were activated, and the microvascular density in the wound site was markedly higher than that in the control group. Conclusions The present study was the first to demonstrate that vaccarin is able to induce angiogenesis and accelerate wound healing in vivo by increasing expressions of p-Akt, p-Erk and p-bFGFR. This process is mediated by MAPK/ERK and PI3K/AKT signaling pathways.(AU)


Sujet(s)
Animaux , Mâle , Rats , Vaccaria , Cicatrisation de plaie , Agents angiogéniques/usage thérapeutique , Modèles animaux
5.
s.l; Fondo Nacional de Recursos; jun. 2018.
Non conventionel de Espagnol | BRISA/RedTESA | ID: biblio-1009169

RÉSUMÉ

INTRODUCCIÓN: La incidencia de cáncer renal ha ido en aumento, constituyendo en Uruguay el 5to cáncer en frecuencia para los hombres y el 10mo para las mujeres en el período 2009-2013. De los pacientes con cáncer de riñón 20-30% debutan con enfermedad metastásica(2­4), presentando una mediana de supervivencia menor a un año. Entre aquellos con enfermedad localizada 20-50% desarrollan metástasis en la evolución. Previo al advenimiento de las terapias dirigidas el pronóstico de los pacientes con cáncer renal avanzado era muy sombrío, con una supervivencia a 5 años menor a 10%. El cáncer de riñón metastásico se encuentra entre los más resistentes a los tratamientos sistémicos, con muy escasas opciones terapéuticas hasta la introducción de las terapias dirigidas. Los inhibidores de tirosina-quinasa como sunitinib, sorafenib y pazopanib han demostrado en diversos ensayos clínicos efectividad para el tratamiento, con medianas de supervivencia global entre 19,3 y 26,4 meses en pacientes con cáncer renal avanzado. Éstos fármacos son de administración oral y actúan bloqueando receptores del factor de crecimiento endotelial vascular presentando acciones anti-angiogénicas y antiproliferativas. Sunitinib y pazopanib son actualmente los más utilizados en primera línea. OBJETIVOS: Analizar los resultados de los pacientes con cáncer de riñón metastásico tratados con sunitinib, sorafenib o pazopanib en primera línea bajo cobertura del FNR que iniciaron tratamiento entre el 1o enero de 2009 hasta el 30 de junio de 2016. Comparar los resultados de quienes recibieron sunitinib y pazopanib en primera línea en esta población. METODOLOGÍA: Se realizó un estudio prospectivo de la cohorte de pacientes con cáncer de riñón metastásico que iniciaron tratamiento con inhibidores de la tirosina-quinasa en primera línea bajo cobertura del FNR entre el 1o enero de 2009 y el 30 de junio de 2016. El seguimiento finalizó el 30 de mayo de 2017. Se excluyeron los pacientes que no retiraron ninguna dosis del fármaco aprobado. RESULTADOS: Desde el 1o de enero de 2009 al 30 de junio de 2016 se recibieron 625 solicitudes de tratamiento con inhibidores de la tirosina-quinasa, siendo autorizadas 545 (87,5%), de las cuales 423 correspondieron a tratamientos de primera línea. Se excluyeron 17 pacientes que nunca retiraron la medicación, de los cuales 14 fallecieron previo al mes de considerada la solicitud. Se analizan los datos correspondientes a los 406 pacientes que iniciaron tratamiento, de los cuales 284 recibieron sunitinib, 114 pazopanib y 8 sorafenib. En cuanto a las características demográficas de los pacientes encontramos que la media de edad fue de 61,6 años (rango 27-85), con predominio del sexo masculino 291 pacientes (71,7 %). En cuanto a la procedencia 219 pacientes (53,9%) eran del interior del país y 187 pacientes (46,1%) de Montevideo. Respecto a la cobertura asistencial en 311 pacientes (76,6%) fue privada. CONCLUSIONES: El análisis comparativo de los pacientes tratados con sunitinib o pazopanib en primera línea mostró que no existe diferencia en la respuesta, supervivencia global ni en la supervivencia libre de progresión entre ambos tratamientos. La frecuencia global de efectos adversos en ambos tratamientos fue similar, sin embargo la frecuencia de efectos adversos hematológicos, cardiovasculares, dermatológicos y endocrinológicos fue mayor en los pacientes tratados con sunitinib. Coincidentemente la frecuencia de cambio de fármaco fue mayor en los pacientes tratados con sunitinib. Por lo tanto ambos fármacos mostraron similar eficacia y el pazopanib un mejor perfil de seguridad.


Sujet(s)
Agents angiogéniques/usage thérapeutique , Ressources Financières en Santé , Sorafénib/usage thérapeutique , Sunitinib/usage thérapeutique , Tumeurs du rein/traitement médicamenteux , Analyse coût-bénéfice/économie , Financement des soins de santé
6.
Acta Cir Bras ; 32(9): 726-735, 2017 Sep.
Article de Anglais | MEDLINE | ID: mdl-29019590

RÉSUMÉ

PURPOSE: To investigated the inflammatory, angiogenic and fibrogenic activities of the Schinus terebinthifolius Raddi leaves oil (STRO) on wound healing. METHODS: The excisional wound healing model was used to evaluate the effects of STRO. The mice were divided into two groups: Control, subjected to vehicle solution (ointment lanolin/vaseline base), or STRO- treated group, administered topically once a day for 3, 7 and 14 days post-excision. We evaluated the macroscopic wound closure rate; the inflammation was evaluated by leukocytes accumulation and cytokine levels in the wounds. The accumulation of neutrophil and macrophages in the wounds were determined by assaying myeloperoxidase and N-acetyl-ß-D-glucosaminidase activities. The levels of TNF-α, CXCL-1 and CCL-2 in wound were evaluated by ELISA assay. Angiogenesis and collagen fibers deposition were evaluated histologically. RESULTS: We observed that macroscopic wound closure rate was improved in wounds from STRO-group than Control-group. The wounds treated with STRO promoted a reduction in leucocyte accumulation and in pro-inflammatory cytokine. Moreover, STRO treatment increased significantly the number of blood vessels and collagen fibers deposition, as compared to control group. CONCLUSION: Topical application of STRO display anti-inflammatory and angiogenic effects, as well as improvement in collagen replacement, suggesting a putative use of this herb for the development of phytomedicines to treat inflammatory diseases, including wound healing.


Sujet(s)
Anacardiaceae/composition chimique , Agents angiogéniques/usage thérapeutique , Inflammation/traitement médicamenteux , Extraits de plantes/usage thérapeutique , Huiles végétales/usage thérapeutique , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Animaux , Collagène/analyse , Immunohistochimie , Mâle , Souris , Feuilles de plante/composition chimique , Tissu sous-cutané/effets des médicaments et des substances chimiques , Tissu sous-cutané/anatomopathologie , Facteurs temps
7.
Acta cir. bras ; Acta cir. bras;32(9): 726-735, Sept. 2017. graf
Article de Anglais | LILACS | ID: biblio-886240

RÉSUMÉ

Abstract Purpose: To investigated the inflammatory, angiogenic and fibrogenic activities of the Schinus terebinthifolius Raddi leaves oil (STRO) on wound healing. Methods: The excisional wound healing model was used to evaluate the effects of STRO. The mice were divided into two groups: Control, subjected to vehicle solution (ointment lanolin/vaseline base), or STRO- treated group, administered topically once a day for 3, 7 and 14 days post-excision. We evaluated the macroscopic wound closure rate; the inflammation was evaluated by leukocytes accumulation and cytokine levels in the wounds. The accumulation of neutrophil and macrophages in the wounds were determined by assaying myeloperoxidase and N-acetyl-β-D-glucosaminidase activities. The levels of TNF-α, CXCL-1 and CCL-2 in wound were evaluated by ELISA assay. Angiogenesis and collagen fibers deposition were evaluated histologically. Results: We observed that macroscopic wound closure rate was improved in wounds from STRO-group than Control-group. The wounds treated with STRO promoted a reduction in leucocyte accumulation and in pro-inflammatory cytokine. Moreover, STRO treatment increased significantly the number of blood vessels and collagen fibers deposition, as compared to control group. Conclusion: Topical application of STRO display anti-inflammatory and angiogenic effects, as well as improvement in collagen replacement, suggesting a putative use of this herb for the development of phytomedicines to treat inflammatory diseases, including wound healing.


Sujet(s)
Animaux , Mâle , Rats , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Huiles végétales/usage thérapeutique , Extraits de plantes/usage thérapeutique , Anacardiaceae/composition chimique , Agents angiogéniques/usage thérapeutique , Inflammation/traitement médicamenteux , Facteurs temps , Immunohistochimie , Collagène/analyse , Feuilles de plante/composition chimique , Tissu sous-cutané/effets des médicaments et des substances chimiques , Tissu sous-cutané/anatomopathologie
8.
Acta Cir Bras ; 31(7): 463-71, 2016 Jul.
Article de Anglais | MEDLINE | ID: mdl-27487281

RÉSUMÉ

PURPOSE: To evaluate the effects of low intensity ultrasound on the healing process of third degree burn wounds in experimentally induced diabetic Wistar rats. METHODS: One hundred rats were divided into: control group; non-diabetic treated group; diabetic control group; diabetic treated group. The therapy was performed with a 3MHz ultrasound application, pulsed emission at 100Hz frequency, modulated at 20% with a dosage of 0.5W/cm2 during three minutes throughout 30 days. The surgical debridement of the wound was performed once at day 2. The wounds were morphometrically, macroscopically and microscopically evaluated at 3, 7, 14, 21 and 30 days. RESULTS: The wound contraction and collagen quantification were higher in all treated groups. Macroscopically, necrosis was higher in the diabetic control group. Granulation tissue was higher in treated groups during the proliferative and remodeling phase. Microscopically, there were greater mononuclear inflammatory infiltration, angiogenesis and fibroblast quantification in treated groups during the proliferative and remodeling phases. CONCLUSIONS: therapeutic ultrasound is beneficial in the inflammatory and proliferative phases of the healing process because it controlled the necrotic tissue, increased the granulation tissue and wound contraction. However in the remodeling phase it is not beneficial because of the continued angiogenesis and a mononuclear inflammatory infiltration.


Sujet(s)
Agents angiogéniques/usage thérapeutique , Brûlures/thérapie , Diabète expérimental , Peau/traumatismes , Ultrasonothérapie/méthodes , Cicatrisation de plaie/physiologie , Animaux , Brûlures/anatomopathologie , Collagène/analyse , Diabète expérimental/complications , Diabète expérimental/thérapie , Femelle , Fibroblastes/anatomopathologie , Tissu de granulation/anatomopathologie , Modèles animaux , Nécrose/anatomopathologie , Nécrose/rééducation et réadaptation , Rat Wistar
9.
Acta cir. bras ; Acta cir. bras;31(7): 463-471, tab, graf
Article de Anglais | LILACS | ID: lil-787263

RÉSUMÉ

ABSTRACT PURPOSE: To evaluate the effects of low intensity ultrasound on the healing process of third degree burn wounds in experimentally induced diabetic Wistar rats. METHODS: One hundred rats were divided into: control group; non-diabetic treated group; diabetic control group; diabetic treated group. The therapy was performed with a 3MHz ultrasound application, pulsed emission at 100Hz frequency, modulated at 20% with a dosage of 0.5W/cm2 during three minutes throughout 30 days. The surgical debridement of the wound was performed once at day 2. The wounds were morphometrically, macroscopically and microscopically evaluated at 3, 7, 14, 21 and 30 days. RESULTS: The wound contraction and collagen quantification were higher in all treated groups. Macroscopically, necrosis was higher in the diabetic control group. Granulation tissue was higher in treated groups during the proliferative and remodeling phase. Microscopically, there were greater mononuclear inflammatory infiltration, angiogenesis and fibroblast quantification in treated groups during the proliferative and remodeling phases. CONCLUSIONS: therapeutic ultrasound is beneficial in the inflammatory and proliferative phases of the healing process because it controlled the necrotic tissue, increased the granulation tissue and wound contraction. However in the remodeling phase it is not beneficial because of the continued angiogenesis and a mononuclear inflammatory infiltration.


Sujet(s)
Animaux , Femelle , Peau/traumatismes , Ultrasonothérapie/méthodes , Cicatrisation de plaie/physiologie , Brûlures/thérapie , Agents angiogéniques/usage thérapeutique , Diabète expérimental , Brûlures/anatomopathologie , Collagène/analyse , Rat Wistar , Modèles animaux , Diabète expérimental/complications , Diabète expérimental/thérapie , Fibroblastes/anatomopathologie , Tissu de granulation , Nécrose/anatomopathologie , Nécrose/rééducation et réadaptation
10.
Pesqui. vet. bras ; 36(2): 108-118, fev. 2016. graf, ilus
Article de Portugais | VETINDEX | ID: vti-324144

RÉSUMÉ

Feridas de grandes extensões, com perda da viabilidade tecidual e retardo na cicatrização por segunda intenção são casos que se faz necessário o emprego de técnicas cirúrgicas reconstrutivas. O plasma rico em plaquetas (PRP) é um produto com maior concentração plaquetária, adjuvante no processo cicatricial de cirurgias reconstrutivas, auxiliando nos processos de hemostasia e estimulação da angiogênese. Dessa forma, delineou-se um estudo a fim de avaliar a eficácia do uso do gel produzido a partir do plasma rico em plaquetas (PRP) em flapes de avanço de padrão axial toracodorsal em coelhos, para avaliar a possibilidade de favorecer a integração do retalho no leito receptor. Utilizaram-se 30 coelhos da raça Nova Zelândia branco, separados em dois grupos de 15 animais, compreendendo os grupos plasma rico em plaquetas (GPRP), na qual empregou-se o gel antes da síntese da ferida cirúrgica, e controle (GC), na qual utilizou-se apenas solução fisiológica. Para obtenção do PRP, coletou-se sangue dos animais, e determinou-se a contagem plaquetária antes da preparação do gel. No início e término do experimento os animais foram pesados para posterior análise de ganho peso médio. Após o procedimento cirúrgico iniciou-se as avaliações macroscópicas no 3º, 7º e 14º dia, e avaliou-se presença ou ausência de exsudato, integridade da pele, edema, rubor e necrose. Após esta etapa, coletou-se o material da ferida cirúrgica para confecção das lâminas histológicas e posterior avaliação microscópica. Avaliou-se a proliferação vascular, presença de células mononucleares e polimorfonucleares, proliferação fibroblástica, colagenização, reepitelização e hemorragia. Os dados obtidos foram submetidos à análise estatística (Teste t Student, t emparalhado, e Kruskall Walis, sendo p<0,05)[...](AU)


Wounds of large tracts with loss of tissue viability and delayed healing by secondary intention are cases where it is necessary the use of reconstructive surgical techniques. The platelet rich plasma (PRP) is a product with a higher platelet concentration, adjuvant in the healing process of reconstructive surgeries, assisting in the processes of hemostasis and stimulation of angiogenesis. Thus, a study was devised to assess the efficacy of the gel produced from the platelet rich plasma (PRP) in the forward axial flaps thoracodorsal pattern in rabbits to evaluate the ability to promote the integration of the flap the recipient bed. We used 30 white rabbits New Zealand, separated into two groups of 15 animals, comprising the platelet rich plasma groups (GPRP), in which we used the gel before the synthesis of the surgical wound , and control (CG), in which only saline was used. To obtain the PRP, the blood was collected from the animals, was determined and the platelet count before preparation of the gel. At the beginning and end of the experiment the animals were weighed for analysis of average weight gain. After surgery began macroscopic in the 3rd, 7th and 14th day reviews, and we assessed the presence or absence of exudate, skin integrity, edema, redness and necrosis. After this step, yielded the material for the manufacture of surgical wound, followed by microscopic histological slides. We evaluated vascular proliferation, presence of polymorphonuclear and mononuclear cells, fibroblast proliferation, collagen deposition, reepithelialization and hemorrhage. The data were subjected to statistical analysis (Student t test, t paired, and Kruskal Wallis test, and p<0.05)[...](AU)


Sujet(s)
Animaux , 33584/médecine vétérinaire , Lapins/chirurgie , Lambeaux tissulaires libres/transplantation , Plasma riche en plaquettes , Agents angiogéniques/usage thérapeutique , Thorax/transplantation , Dos/chirurgie , Plaies et blessures/chirurgie
11.
Pesqui. vet. bras ; Pesqui. vet. bras;36(2): 108-118, fev. 2016. graf
Article de Portugais | LILACS | ID: lil-777389

RÉSUMÉ

Feridas de grandes extensões, com perda da viabilidade tecidual e retardo na cicatrização por segunda intenção são casos que se faz necessário o emprego de técnicas cirúrgicas reconstrutivas. O plasma rico em plaquetas (PRP) é um produto com maior concentração plaquetária, adjuvante no processo cicatricial de cirurgias reconstrutivas, auxiliando nos processos de hemostasia e estimulação da angiogênese. Dessa forma, delineou-se um estudo a fim de avaliar a eficácia do uso do gel produzido a partir do plasma rico em plaquetas (PRP) em flapes de avanço de padrão axial toracodorsal em coelhos, para avaliar a possibilidade de favorecer a integração do retalho no leito receptor. Utilizaram-se 30 coelhos da raça Nova Zelândia branco, separados em dois grupos de 15 animais, compreendendo os grupos plasma rico em plaquetas (GPRP), na qual empregou-se o gel antes da síntese da ferida cirúrgica, e controle (GC), na qual utilizou-se apenas solução fisiológica. Para obtenção do PRP, coletou-se sangue dos animais, e determinou-se a contagem plaquetária antes da preparação do gel. No início e término do experimento os animais foram pesados para posterior análise de ganho peso médio. Após o procedimento cirúrgico iniciou-se as avaliações macroscópicas no 3º, 7º e 14º dia, e avaliou-se presença ou ausência de exsudato, integridade da pele, edema, rubor e necrose. Após esta etapa, coletou-se o material da ferida cirúrgica para confecção das lâminas histológicas e posterior avaliação microscópica. Avaliou-se a proliferação vascular, presença de células mononucleares e polimorfonucleares, proliferação fibroblástica, colagenização, reepitelização e hemorragia. Os dados obtidos foram submetidos à análise estatística (Teste t Student, t emparalhado, e Kruskall Walis, sendo p<0,05)[...]


Wounds of large tracts with loss of tissue viability and delayed healing by secondary intention are cases where it is necessary the use of reconstructive surgical techniques. The platelet rich plasma (PRP) is a product with a higher platelet concentration, adjuvant in the healing process of reconstructive surgeries, assisting in the processes of hemostasis and stimulation of angiogenesis. Thus, a study was devised to assess the efficacy of the gel produced from the platelet rich plasma (PRP) in the forward axial flaps thoracodorsal pattern in rabbits to evaluate the ability to promote the integration of the flap the recipient bed. We used 30 white rabbits New Zealand, separated into two groups of 15 animals, comprising the platelet rich plasma groups (GPRP), in which we used the gel before the synthesis of the surgical wound , and control (CG), in which only saline was used. To obtain the PRP, the blood was collected from the animals, was determined and the platelet count before preparation of the gel. At the beginning and end of the experiment the animals were weighed for analysis of average weight gain. After surgery began macroscopic in the 3rd, 7th and 14th day reviews, and we assessed the presence or absence of exudate, skin integrity, edema, redness and necrosis. After this step, yielded the material for the manufacture of surgical wound, followed by microscopic histological slides. We evaluated vascular proliferation, presence of polymorphonuclear and mononuclear cells, fibroblast proliferation, collagen deposition, reepithelialization and hemorrhage. The data were subjected to statistical analysis (Student t test, t paired, and Kruskal Wallis test, and p<0.05)[...]


Sujet(s)
Animaux , Lapins/chirurgie , Plasma riche en plaquettes , 33584/médecine vétérinaire , Lambeaux tissulaires libres/transplantation , Dos/chirurgie , Plaies et blessures/chirurgie , Agents angiogéniques/usage thérapeutique , Thorax/transplantation
12.
Braz. j. otorhinolaryngol. (Impr.) ; Braz. j. otorhinolaryngol. (Impr.);82(1): 17-25, Jan.-Feb. 2016. tab, graf
Article de Portugais | LILACS | ID: lil-775702

RÉSUMÉ

ABSTRACT INTRODUCTION: Bismuth subgallate is a salt derived from heavy metal. The aim of this study was to evaluate the effect of this salt on some phases of healing. OBJECTIVES: To assess the effect of subgallate on mucosa and to evaluate the association between the use of bismuth subgallate and neogenesis of vessels in oral mucosal wounds. METHODS: This was a prospective and experimental study. This study used sixty rats, which were divided into control and experimental groups. The animals were submitted to a surgical procedure, which caused oral mucosal injury. A saline solution was applied on the wound of the control group, and in the experimental group, a solution of bismuth subgallate was administrated. RESULTS: The experimental group showed greater inflammatory reaction with increasing monomorphic proliferation. There was increased vessel proliferation in the control group. CONCLUSION: Bismuth subgallate had a negative influence on the healing process, delaying the rate of new vessel formation and optimal wound healing.


RESUMO INTRODUÇÃO: O subgalato de bismuto é um sal derivado de metal pesado. A ideia desta pesquisa é avaliar sua interferência em alguma das fases da cicatrização. OBJETIVO: Delinear a ação do subgalato em mucosas. Avaliar a relação entre a utilização do subgalato de bismuto e a neoformação de vasos nas feridas em mucosa oral, para evidenciar o possível benefício resultante do seu uso. MÉTODO: Estudo experimental, prospectivo. Utilizou-se sessenta ratos, que foram divididos igualmente em grupo controle e experimento. Foram submetidos a um procedimento cirúrgico onde foi feito uma lesão na mucosa oral dos animais, após, uma solução de soro fisiológico foi aplicada sobre a lesão do grupo controle e sobre a ferida do grupo experimento foi aplicada uma solução de subgalato de bismuto. RESULTADOS: o grupo experimento apresentou maior reação inflamatória com crescente proliferação monomórfica. Vasos: houve maior proliferação no grupo controle. CONCLUSÕES: concluiu-se que o subgalato de bismuto teve uma ação negativa no processo de cicatrização, atrasando a velocidade de formação dos neovasos e a cicatrização ideal da ferida operatória.


Sujet(s)
Animaux , Humains , Mâle , Rats , Agents angiogéniques/usage thérapeutique , Acide gallique/analogues et dérivés , Composés organométalliques/usage thérapeutique , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Modèles animaux de maladie humaine , Acide gallique/usage thérapeutique , Muqueuse de la bouche/vascularisation , Muqueuse de la bouche/chirurgie , Études prospectives , Amygdalectomie
13.
Braz J Otorhinolaryngol ; 82(1): 17-25, 2016.
Article de Anglais | MEDLINE | ID: mdl-26614041

RÉSUMÉ

INTRODUCTION: Bismuth subgallate is a salt derived from heavy metal. The aim of this study was to evaluate the effect of this salt on some phases of healing. OBJECTIVES: To assess the effect of subgallate on mucosa and to evaluate the association between the use of bismuth subgallate and neogenesis of vessels in oral mucosal wounds. METHODS: This was a prospective and experimental study. This study used sixty rats, which were divided into control and experimental groups. The animals were submitted to a surgical procedure, which caused oral mucosal injury. A saline solution was applied on the wound of the control group, and in the experimental group, a solution of bismuth subgallate was administrated. RESULTS: The experimental group showed greater inflammatory reaction with increasing monomorphic proliferation. There was increased vessel proliferation in the control group. CONCLUSION: Bismuth subgallate had a negative influence on the healing process, delaying the rate of new vessel formation and optimal wound healing.


Sujet(s)
Agents angiogéniques/usage thérapeutique , Acide gallique/analogues et dérivés , Composés organométalliques/usage thérapeutique , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Animaux , Modèles animaux de maladie humaine , Acide gallique/usage thérapeutique , Humains , Mâle , Muqueuse de la bouche/vascularisation , Muqueuse de la bouche/chirurgie , Études prospectives , Rats , Amygdalectomie
15.
Wound Repair Regen ; 22(4): 497-503, 2014.
Article de Anglais | MEDLINE | ID: mdl-25041620

RÉSUMÉ

The healing process in diabetic foot ulcer (DFU) is hindered by factors such as chronic inflammation, defects in fibroblast function, poor angiogenesis, and lack of cell migration. Recombinant human epidermal growth factor (rhEGF) has been shown to enhance extracellular matrix formation, cellular proliferation, and angiogenesis. Therefore, intralesional application of rhEGF in DFU could accelerate wound healing. Our objective was to determine the efficacy and safety of rhEGF in patients with DFU. A randomized, double-blinded, placebo-controlled study was conducted comparing a thrice-per-week intralesional application of rhEGF (75 µg) or placebo in patients with DFU for 8 weeks. The number of completely healed ulcers, size, and wound bed characteristics were evaluated to determine the efficacy of rhEGF. Adverse events were recorded and analyzed to establish its safety. A total of 34 patients were recruited for the study. After three dropouts, we were able to follow and analyze 16 patients in the placebo group and 15 patients in the rhEGF study to the end of the trial. Baseline testing showed that both groups were similar. Compared to the placebo group, more ulcers achieved complete healing in the rhEGF group (rhEGF, n = 4; placebo, n = 0; p = 0.033); ulcers in the rhEGF group decreased in area size (12.5 cm2 [rhEGF] vs. 5.2 cm2 [placebo]; p = 0.049); and more epithelial islands in the wound bed were present (28% vs. 3%; p = 0.025). Mild transitory dizziness was the only side effect that was more frequently noted in the rhEGF group. Our results showed that in patients with DFU who received standard care, intralesional rhEGF application resulted in complete healing in more patients, promoted the epithelialization of the wound bed, and significantly reduced the area of the DFU treated. Therefore, rhEGF resulted in better outcomes for patients suffering from DFU.


Sujet(s)
Agents angiogéniques/usage thérapeutique , Pied diabétique/traitement médicamenteux , Facteur de croissance épidermique/usage thérapeutique , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Adulte , Amputation chirurgicale , Prolifération cellulaire/effets des médicaments et des substances chimiques , Pied diabétique/anatomopathologie , Pied diabétique/physiopathologie , Relation dose-effet des médicaments , Méthode en double aveugle , Femelle , Tissu de granulation/effets des médicaments et des substances chimiques , Humains , Injections intralésionnelles , Mâle , Mexique/épidémiologie , Protéines recombinantes/usage thérapeutique , Résultat thérapeutique
16.
Acta Cir Bras ; 28(3): 202-9, 2013 Mar.
Article de Anglais | MEDLINE | ID: mdl-23503862

RÉSUMÉ

PURPOSE: To evaluate the effects of aroeira (Schinus terebinthifolius) ointment on skin wound healing in rats. METHODS: Adult male rats (n=20) were divided into four groups of five animals each, as follows: G4, G7, G14 and G21, which corresponds to 4th, 7th, 14th and 21th days postoperatively. Each animal were made two incisions on the skin, including the subcutaneous tissue, in the right and left sides of thoracic region, separated by a distance of two inches. The right lesion was treated with base ointment (vaseline, lanolin); the left one was treated with base ointment containing 5% of aroeira oil. At the end of each experimental period the lesions were evaluated for the contraction degree. Then held the collection of fragments that were fixed in 10% formalin and processed for paraffin embedding. In the histological sections (5µm) was evaluated the morphology and quantified the collagen and blood vessels. The data obtained were submitted to ANOVA test complemented by Tukey-Kramer test (p<0.05). RESULTS: The contraction of the lesions was higher in wounds treated with aroeira oil than in controls at 7th and 14th days (p<0.01), whereas in the 21st day all lesions were already completely healed. The morphology showed granulation tissue more developed, with fibroblasts more bulky and collagen fibers more arranged in the experimental group at 4th, 7th and 14th days. The morphometry showed a significant increase in the quantification of collagen fibers in the experimental group at 7th and 14th days (p<0.05). CONCLUSION: The aroeira oil accelerates the healing process of wounds as a macroscopic, morphological and morphometrical analysis.


Sujet(s)
Anacardiaceae , Extraits de plantes/usage thérapeutique , Huiles végétales/usage thérapeutique , Tissu sous-cutané/effets des médicaments et des substances chimiques , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Agents angiogéniques/usage thérapeutique , Animaux , Collagène/analyse , Immunohistochimie , Mâle , Phytothérapie , Période postopératoire , Rats , Tissu sous-cutané/anatomopathologie , Facteurs temps , Résultat thérapeutique
17.
Acta cir. bras ; Acta cir. bras;28(3): 202-209, Mar. 2013. ilus, tab
Article de Anglais | LILACS | ID: lil-667931

RÉSUMÉ

PURPOSE: To evaluate the effects of aroeira (Schinus terebinthifolius) ointment on skin wound healing in rats. METHODS: Adult male rats (n=20) were divided into four groups of five animals each, as follows: G4, G7, G14 and G21, which corresponds to 4th, 7th, 14th and 21th days postoperatively. Each animal were made two incisions on the skin, including the subcutaneous tissue, in the right and left sides of thoracic region, separated by a distance of two inches. The right lesion was treated with base ointment (vaseline, lanolin); the left one was treated with base ointment containing 5% of aroeira oil. At the end of each experimental period the lesions were evaluated for the contraction degree. Then held the collection of fragments that were fixed in 10% formalin and processed for paraffin embedding. In the histological sections (5μm) was evaluated the morphology and quantified the collagen and blood vessels. The data obtained were submitted to ANOVA test complemented by Tukey-Kramer test (p<0.05). RESULTS: The contraction of the lesions was higher in wounds treated with aroeira oil than in controls at 7th and 14th days (p<0.01), whereas in the 21st day all lesions were already completely healed. The morphology showed granulation tissue more developed, with fibroblasts more bulky and collagen fibers more arranged in the experimental group at 4th, 7th and 14th days. The morphometry showed a significant increase in the quantification of collagen fibers in the experimental group at 7th and 14th days (p<0.05). CONCLUSION: The aroeira oil accelerates the healing process of wounds as a macroscopic, morphological and morphometrical analysis.


Sujet(s)
Animaux , Mâle , Rats , Anacardiaceae , Extraits de plantes/usage thérapeutique , Huiles végétales/usage thérapeutique , Tissu sous-cutané/effets des médicaments et des substances chimiques , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Agents angiogéniques/usage thérapeutique , Collagène/analyse , Immunohistochimie , Phytothérapie , Période postopératoire , Tissu sous-cutané/anatomopathologie , Facteurs temps , Résultat thérapeutique
18.
Acta Cir Bras ; 27(10): 655-70, 2012 Oct.
Article de Anglais | MEDLINE | ID: mdl-23033126

RÉSUMÉ

PURPOSE: To study the effects of the angico extract (Anadenanthera colubrina var. cebil) on the healing of rat skin. METHODS: Twenty adult rats were divided into four groups of five animals each, the G4, G7, G14 and G21, which corresponds to the respective postoperative days. Each group received two incisions on skin and subcutaneous tissue in the right and left antimere of the thoracic region, separated by a distance of 2 cm. The right lesion was treated daily with saline and the left with the angico alcoholic extract (5%). At the end of each experimental period, animals were euthanized and fragments of the wound area, together with the edges were removed, fixed in 10% formaldehyde solution and processed for paraffin embedding. In the histological sections with 5 µm of thickness, were carried out immunohistochemical methods for detection of blood vessels (VEGF) and stained with hematoxylin and eosin for morphological analysis. Statistical analysis was done by ANOVA and Tukey test (p<0.05). RESULTS: Morphological analysis showed larger fibroblasts and a higher concentration of collagen fibers in days 7 and 14 in wounds treated with the angico extract. Morphometric analysis demonstrated a significant increase in the number of blood vessels in both the seventh and 14th days (p<0.01) in wounds treated with the angico extract. CONCLUSION: The angico alcoholic extract (Anadenanthera colubrina var. cebil) induces the acceleration of wound healing in skin wounds of rats.


Sujet(s)
Fabaceae , Phytothérapie , Extraits de plantes/usage thérapeutique , Peau/traumatismes , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Agents angiogéniques/usage thérapeutique , Animaux , Modèles animaux de maladie humaine , Fibroblastes/effets des médicaments et des substances chimiques , Mâle , Rats , Tissu sous-cutané/effets des médicaments et des substances chimiques , Facteurs temps , Résultat thérapeutique
19.
Acta cir. bras. ; 27(10): 655-670, 2012. ilus, tab
Article de Anglais | VETINDEX | ID: vti-14215

RÉSUMÉ

PURPOSE: To study the effects of the angico extract (Anadenanthera colubrina var. cebil) on the healing of rat skin. METHODS: Twenty adult rats were divided into four groups of five animals each, the G4, G7, G14 and G21, which corresponds to the respective postoperative days. Each group received two incisions on skin and subcutaneous tissue in the right and left antimere of the thoracic region, separated by a distance of 2 cm. The right lesion was treated daily with saline and the left with the angico alcoholic extract (5%). At the end of each experimental period, animals were euthanized and fragments of the wound area, together with the edges were removed, fixed in 10% formaldehyde solution and processed for paraffin embedding. In the histological sections with 5 µm of thickness, were carried out immunohistochemical methods for detection of blood vessels (VEGF) and stained with hematoxylin and eosin for morphological analysis. Statistical analysis was done by ANOVA and Tukey test (p<0.05). RESULTS: Morphological analysis showed larger fibroblasts and a higher concentration of collagen fibers in days 7 and 14 in wounds treated with the angico extract. Morphometric analysis demonstrated a significant increase in the number of blood vessels in both the seventh and 14th days (p<0.01) in wounds treated with the angico extract. CONCLUSION: The angico alcoholic extract (Anadenanthera colubrina var. cebil) induces the acceleration of wound healing in skin wounds of rats.(AU)


OBJETIVO: Avaliar os efeitos do extrato de angico (Anadenanthera colubrina var. cebil) na cicatrização em pele de ratos. MÉTODOS: Ratos machos adultos (n=20) foram distribuídos em quatro grupos de cinco animais cada, a saber: G4, G7, G14 e G21, o que corresponde a quatro, sete, 14 e 21 dias de pós-operatório. Cada grupo recebeu duas incisões na pele compreendendo o tecido subcutâneo, nos antímeros direito e esquerdo da região torácica, separadas por uma distância de dois cm. A lesão esquerda com extrato alcoólico de angico (5%), iniciando-se logo após a cirurgia por 21 dias consecutivos. Ao final de cada período (4, 7, 14 e 21 de pós-operatório) experimental foram coletados fragmentos da área da ferida, fixada em formol a 10% e processadas para inclusão em parafina. Nos cortes histológicos com 5 µm de espessura, foram realizados métodos imunoistoquímicos para detecção dos vasos sanguíneos (VEGF) e coloração pela hematoxilina para análise morfológica. Os dados obtidos foram submetidos à análise estatística ANOVA complementada pelo teste de Tukey-Kramer (p<0,05). RESULTADOS: A análise morfológica mostrou fibroblastos mais volumosos e alta concentração de fibras colágenas no 7º e 14º dias nas feridas tratadas com extrato de angico. A análise morfométrica demonstrou aumento significativo no número de vasos sanguíneos no sétimo e 14º dias (p<0,01) de pós-operatório em feridas tratadas com extrato de angico. CONCLUSÃO: O extrato hidroalcoólico a 5% da casca e entrecasca do angico (Anadenanthera colubrina var. cebil) acelera a neoangiogênese em feridas cutâneas de ratos.(AU)


Sujet(s)
Animaux , Rats , Agents angiogéniques/administration et posologie , Agents angiogéniques/usage thérapeutique , Modèles animaux , Plantes médicinales , Cicatrisation de plaie , Néovascularisation physiologique , Extraits de plantes/usage thérapeutique , Rats/chirurgie , Rats/physiologie , Interprétation statistique de données
20.
Acta cir. bras ; Acta cir. bras;27(10): 655-670, Oct. 2012. ilus, tab
Article de Anglais | LILACS | ID: lil-650554

RÉSUMÉ

PURPOSE: To study the effects of the angico extract (Anadenanthera colubrina var. cebil) on the healing of rat skin. METHODS: Twenty adult rats were divided into four groups of five animals each, the G4, G7, G14 and G21, which corresponds to the respective postoperative days. Each group received two incisions on skin and subcutaneous tissue in the right and left antimere of the thoracic region, separated by a distance of 2 cm. The right lesion was treated daily with saline and the left with the angico alcoholic extract (5%). At the end of each experimental period, animals were euthanized and fragments of the wound area, together with the edges were removed, fixed in 10% formaldehyde solution and processed for paraffin embedding. In the histological sections with 5 µm of thickness, were carried out immunohistochemical methods for detection of blood vessels (VEGF) and stained with hematoxylin and eosin for morphological analysis. Statistical analysis was done by ANOVA and Tukey test (p<0.05). RESULTS: Morphological analysis showed larger fibroblasts and a higher concentration of collagen fibers in days 7 and 14 in wounds treated with the angico extract. Morphometric analysis demonstrated a significant increase in the number of blood vessels in both the seventh and 14th days (p<0.01) in wounds treated with the angico extract. CONCLUSION: The angico alcoholic extract (Anadenanthera colubrina var. cebil) induces the acceleration of wound healing in skin wounds of rats.


OBJETIVO: Avaliar os efeitos do extrato de angico (Anadenanthera colubrina var. cebil) na cicatrização em pele de ratos. MÉTODOS: Ratos machos adultos (n=20) foram distribuídos em quatro grupos de cinco animais cada, a saber: G4, G7, G14 e G21, o que corresponde a quatro, sete, 14 e 21 dias de pós-operatório. Cada grupo recebeu duas incisões na pele compreendendo o tecido subcutâneo, nos antímeros direito e esquerdo da região torácica, separadas por uma distância de dois cm. A lesão esquerda com extrato alcoólico de angico (5%), iniciando-se logo após a cirurgia por 21 dias consecutivos. Ao final de cada período (4, 7, 14 e 21 de pós-operatório) experimental foram coletados fragmentos da área da ferida, fixada em formol a 10% e processadas para inclusão em parafina. Nos cortes histológicos com 5 µm de espessura, foram realizados métodos imunoistoquímicos para detecção dos vasos sanguíneos (VEGF) e coloração pela hematoxilina para análise morfológica. Os dados obtidos foram submetidos à análise estatística ANOVA complementada pelo teste de Tukey-Kramer (p<0,05). RESULTADOS: A análise morfológica mostrou fibroblastos mais volumosos e alta concentração de fibras colágenas no 7º e 14º dias nas feridas tratadas com extrato de angico. A análise morfométrica demonstrou aumento significativo no número de vasos sanguíneos no sétimo e 14º dias (p<0,01) de pós-operatório em feridas tratadas com extrato de angico. CONCLUSÃO: O extrato hidroalcoólico a 5% da casca e entrecasca do angico (Anadenanthera colubrina var. cebil) acelera a neoangiogênese em feridas cutâneas de ratos.


Sujet(s)
Animaux , Mâle , Rats , Fabaceae , Phytothérapie , Extraits de plantes/usage thérapeutique , Peau/traumatismes , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Agents angiogéniques/usage thérapeutique , Modèles animaux de maladie humaine , Fibroblastes/effets des médicaments et des substances chimiques , Tissu sous-cutané/effets des médicaments et des substances chimiques , Facteurs temps , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE